Home > Insider Trading > Filing (0001380178-15-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Versartis Inc.	VSAR	Pharmaceutical Preparations (2834)	244106690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380178	Shahzad Malik	C/O Advent Life Sciences 158 North Gower Street London X0 NW1 2ND		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-01-22	55,000	$17.25	2,271,558	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See FN

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option (Right to Buy)	$21.00		2024-03-19	35,000	35,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-03-19	35,000	35,000	Direct

Footnotes

Securities are held by Advent Life Sciences LLP ("Advent") and Advent Life Sciences Fund I LP ("Advent Fund"). Advent is the general partner of Advent Fund. The Reporting Person is a partner of Advent, and disclaims beneficial ownership of the shares held by Advent or the Advent Fund except to the extent of his indirect pecuniary interest therein.
One-fourth of the total number of shares subject to the option shall vest and become exercisable one year from 3/21/2014 (the "Vesting Commencement Date") and 1/36th of the remaining number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the Vesting Commencement Date thereafter.